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Abstract Sphingosine-l-phosphate (Sph-l-P), the initial prod- 
uct of.~phingosine (Sph) catabolism, has been reported to inhibit 
motility of mouse melanoma B16/F1 and other types of cells at 
very low coneemraClens (10-]00 nM). Sph-l-P (100 nM-I pM) 
inhibited pseudopodlum formation by bloekJnl~ ~olymerization 
and reorganization of actin filaments in newl~t formed pseudo- 
podia, and reduced F-aetin by ,~2.~% in FI cells, A pyrene- 
labeled aetin nucleation assay revealed that Sph-I-P (100 aM) 
inhibits actln nucleation mediated by t'~l cell plasma membranes. 
These results suggest that Sph-I-P int~vacts with molecules 
associated with aetin nucleation to inhiblt reorg.~r,!z.~t!an of 
pseudopodlum formation and cell motility. 
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1. Introduction 
Sphingosine-l-phosphate (Sph-l-P), the initial product of 
catabolism of Sph by Sph kinase [1], was found to be a strong 
inhibitor (in the nM range) of conditioned medium (CM) and 
extracellular matrix (ECM) induced motility [2,3]. The molec- 
ular basis of the inhibitory effect was unknown. Several bio- 
logical functions of Sph-l-P have been reported. Sph-l-P has 
been shown to he a protein kinase C (PKC)-independent sig- 
naling molecule which mobilizes intracellular Ca 2÷ [4,5] and 
stimulates cellular proliferation [6-9]. Olivera and Spiegel 
claimed that Sph-l-P is a novel second messenger in plate- 
let-derived growth factor- and serum-dependent cell growth 
[10]. Sph kinase activity is highly stimulated by phorbol esters 
in BALB/c 3T3 (A31) cells but not in Swiss 3T3 cells [11]. 
Here we show that the motility-inhibitory effect of Sph-l-P is 
based on inhibition of at/in nucleation, polymerization, and 
reorganization of pseudopodium formatior, 
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sine-l-phosphate; EDTA, ethylenediaminetetraacetic id; PBS, phos- 
phate-buffered saline; SPC, sphingosylphosphorylcboline; Sph, 
sphingosine; Sph-l-P, sphingosine-l-phosphate; TMS, N,N,N-tri- 
methylsphingosine; TMS-I-P, N,N.:rimethylsphingosine-l-phosphatc; 
TPA, 12-O-tetradecanoylphorbol 13-acetate 
2. Materials and methods 
2.1. Cell culture 
BI6 melanoma cell variant FI was obtained from Dr. l.J. Fidler 
(M.D. Anderson Cancer Center, University of Texas, Houston, TX). 
FI cells were cultured in DMEM supplemented with 10% fetal calf 
serum (FCS) (HyCIone, Logan, UT), 2 mM L-glutamine, 2 mM pyru- 
vic acid, 4.5 mg/ml D.glucose, 100 U/ml penicillin G and 100 mg/ml 
streptomycin. 
2.2. Sl, ht~,~gollpicZ,. 
Sph was synthesized from the protected serine aldehyde and lithium 
alkyl derivative [12,13]. N,N.dimothylsphingosine (DMS) was pre- 
pared by reductive amination with HCOOH and NaBH4 [14]. 
N,N,N.trimethylsphingosine (TMS) [I 5] and Sph-i-P [16] were synthe- 
sized as described previously. N,N.dimethyisphingosine-l-phosphate 
(DMS-I-P) and N,N,N.trimethylsphingosine.l-phosphate (TMS-I-P) 
were synthesized [17]. Dihydro-Sph-l-P [15,18] and C2-Cer [19] were 
synthesized as previously described. Sphingosylphosphorylcholine 
(SPC) was purchased from Sigma Chemical Co. (St. Louis, MO) 
and purified by HPLC with CHCIalCHaOH/NH4OH (3:3:1). These 
sphingolipids were dissolved in ethanol/water (!:1), and stored at 
-20°C until required. 
2.3. Morphological study 
F-actin was stained by FITC-labeled phalloidin after cells were 
permeabilized by the method previously described [20], with slight 
modification. Briefly, Lab-Tek cover glass chambers (Nunc, Naper- 
ville, IL) were coated with Matrigel (20 mg/ml) at room temperature 
for 2 h. FI cells were suspended in DMEM containing 2% FCS or 
CM at 5× 104 cells/ml. Test compounds at various concentrations 
were added to the suspension. 0.5 ml of the suspension was seeded 
in chanlbers and allowed to adhere at 37°C. After periods of 2, 3, 4, 
and 18 h, tho coils were observed with phase.contrast microscopy and 
fixed for 30 min by addition of 0.5 ml of 0.1 M phosphate bufer (pH 
7.2) containing 4% paraformaldehyde. The cells were permeabilized 
with 0.2% Triton X-100 for 5 min and incubated with PBS containing 
1% BSA for 30 min. For F.actin staining, the ceils were incubated 
with 0.1 pg/ml FITC-labeled phalloidin (Sigma) for 45 min. 
2.4. Quamifieation fF.actin content 
Quantification of F.actin content was performed essentially aspre- 
viously described [21]. Briefly, 24.well plates (Falcon 8Ill) were 
coated with Matrigel (20 ~tg/ml) indistilled water at room temperature 
- -  | - - - -  • ' ' O for 2 h. F! cells (5 x 10'/ml) were suspended mDMEM containing 2'A, 
FCS or CM, with or without effector lipids. 0.5 ml of the suspension 
was seeded in the coated well and allowed to adhere at 37°C. After 3 h 
incubation, the cells were fixed with 2% paraformaidehyde, p rmea- 
bilized with 0.2% Triton X-100 for 5 rain. and stained with BODIPY 
FL phallacidin (Molecular Probe, Eugene, OR) (5 U/ml) for 45 rain. 
Cells were washed in PBS, and fluorescent dye was extracted from the 
cells in 0.5 ml of 100% methanol for 3(] rain. Fluorescence of the 
methanol extract was measured by fluorometer at 480 nm excitation 
and 515 nm emission. 
2.5. Extraction of plasma membranes 
FI cells were homogenized in a Dounce homogenizer with 20 mM 
MOPS, 0.2 M sucrose, 10 mM EDTA, pH 7.0 at 4°C, and centrifuged 
at 500×g for 10 rain al 4°C. The supernatant was centrifuged at 
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Fill, I, Morphological changes of FI cells induced by various te~:. 
compounds, as observed by phase-contrast microscopy, Cells were 
incubated for 4 h in glass chambers coated with Matrigel, in the 
praen~ of test compounds, (a) CM, (b) CM and 10 nM TPA, 
(¢) CM and I pM Sph-l-P, (d) CM, 10 nM TPA and ! pM Sph-I- 
P, (e) CM and I pg/ml colcemid, (f~ CM and 2 pg/ml cytochalasin 
D, l~eudopodia are indicated by arrows, in the presence of Sph-I- 
P, FI cells spread and elongated but developed no pseudopodia. 
Bar, 40 I, tm, 
7000×g for 10 rain, followed by at 10000×g for 1 h at 4°C, The 
pellet was homogenized in 0,05 M Tris.HCI (pH 7,0) at 4°C, and 
stored at -80QC [22], 5'-Nucleotidase activity [23] as a marker for 
plasma membrane was 9-fold of the activity in the cell homogenate. 
2,6, Acrin labeling 
Pyrene.labeled actin was prepared according to the method of M, 
Canon et al, [24] with slight modifications, Briefly, actin from rabbit 
muscle cell (Sigma, St, Louis, MO) in buffer (0,1 mM CaCl2, 0.2 mM 
ATP, I mM NaHCO~, i mM dithiothreitol, 0,02% NaN,~, pH 7,6) 
was polymerized byaddition of MgCla to 2 mM and KCI to 0,1 M, A 
7,$ molar excess of N-(I-pyret~yl)-iodoacetamide (Mol cular Probes 
Inc,, Eugene, OR) in dimcthylformamide was added immediately after 
addition of KCL The reaction ~ixture was gently rotated in the dark 
for 24 h at room temperature, The F actin was pelleted by centrifuga- 
tion at 180000×g for 2 h at 4°C, The pellet was homo£~nized in 0.2 
mM CaCI2, 0,4 mM ATP, I mM dithiothreitol, 0 02°/o NaNa, 2 mM 
Tris-HCI, pH 8.0, and dialyzed against he same buffer, The homo- 
genate was centrifuged at 180000×g for 30 min at 4°C, and the 
labeled actin was obzained in the supernatant. 
2. 7, Actin nucleation assay 
Various concentrations of Sph-l-P in ethanol-H20 (1:1) were 
added to the homogenate of plasma membranes from FI cells, and 
the sample was preincubated at room temperature for 10 rain. The 
nucleation assay was performed by the addition of buffer (0.4 mM 
ATP, 25 mM imidazole, pH 7.0, final concentrations) and pyrene- 
labeled actin to the sample. Fluorescence was measured with an LS- 
2B filter fluorometer (Perkin-Elmer Corp., Pomona, CA) at wave- 
lengths of 366/407 nm [24,25]. Final concentration of ethanol was 
<0.25%, which did not affect actin nucleation. 
Fig, 2. FITC-phaUoidin staining of FI cells treated with CM, TPA, 
and/or Sph-I-P. FI cells were incubated for 4 h, and stained with 
FITC-phaUoidin. (a~) CM. (d,e) CM and 10 nM TPA. if, g) CM 
and 1 pM Sph-l-P. (h) CM, 10 nM TPA and 1 ttM Sph-l-P. F-ac- 
tin filaments are abundant in pseudopodia (lamellipodia), and some- 
times form ring-like structures in CM-treated cells. TPA treatment 
leads to stronger peripheral staining, suggesting active membrane 
ruffling. Sph-l-P-treated cells show stress fibers but neither ing-like 
structures nor clear peripheral staining. Bar, 40 pm. 
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2.8. Measurement of intracellular Ca 2+ 
U l cells, harvested with brief trypsin-EDTA treatment and resus- 
pended in DMEM with 2% FCS, were added to Lab-Tek cover glass 
chambers precoated with Matrigel, and cultured overnight. Cultures 
were washed with PBS and labeled with 3 ttM Indo-llAM (Molecular 
Probe) at 37°C for 60 rain. Cells were washed with PBS supplemented 
with 1 g/l glucose, rinsed in 0.5 ml of buffer, and subjected to simul- 
Fig. 3. Effects of Sph-l-P and other sphingolipids on actin nuclea- 
tion mediated by F1 cell plasma membranes. (A) Time course of ac- 
tin nucleation. Actin concentration was 8 ~tM (10% labeled with 
pyrene), and membrane concentration was 7 I~g/ml. o, without Sph- 
1-P. ¢, 100 nM Sph-l-P. O, without membranes. (B) Dose depen- 
dence of Sph-l-P inhibition of actin nucleation. Concentrations of 
actin and membranes were the same as those in panel A. Increase 
of fluorescence intensity at 15 min was compared with that of con- 
trol (without Sph-l-P). (C) Comparative ffects of sphingolipids 
(100 nM). Concentrations of actin and membranes were the same as 
those in panel A. Increase of fluorescence intensity at 15 min was 
compared with that of control (without Sph-l-P). The results are 
presented as mean + SE of percent relative to control (n = 3 or 4). 
,t-. 
taneous dual wavelengti~ detection imaging with an ACAS 470 Inter- 
active Laser Cytometer (l~.~ridian I struments, Okemos, MI). Effec- 
tot lipids were dissolved ;.a the buffer at 37°C, and 0.5 ml of the 
diluted lipid wa~ addcd to the chamber. Changes in intracellular 
Ca 2+ levels were measured as changes in fluorescence ratio by meas- 
uring the fluorescent emission at 405 and 480 nm with two-dimen- 
sional scans. 
3. Results ahd discussion 
F! cells on Matrigel-coated plates stimulated by CM pro- 
duced pseudopodia or fiat, extended, 'ruffled' cytoplasmic 
edges (Fig. la). Cell spreading and pseudopodium formation 
in response to CM and Matrigel were significantly enhanced 
by addition of TPA (10 nM), which induced elongated, stalk- 
like processes (Fig. lb). TMS (1 ~tM), a strong PKC inhibitor, 
did not inhibit pseudopodium formation even in the presence 
of TPA. However, in the presence of Sph-l-P (1 llM), cells 
kept the elongated shape but exhibited no formation of pseu- 
dopodium (Fig. lc,d). These results strongly agreed with those 
of cell motility inhibition by these compounds [2,3]. The mor- 
phological changes induced by Sph-l-P appeared entirely dif- 
ferent from those induced by colcemid and cytochalasin D, in 
which cell polarization and spreading disappeared ue to 
complete disorganization of the cytoskeletal structures of mi- 
crotubules (colcemid) and microfilaments (cytochalasin D) 
(Fig. Is,f). 
The polarization of actin was clearly observed after staining 
with FITC.labeled phalloidin. FITC.phalloidin staining dem- 
onstrated marked F-actin deposition at the active edge of 
pseudopodia (Fig. 2a-c). Some cells (9-20%) showed a circu- 
lar arrangement of F-actin filaments (Fig. 2b), similar to the 
previously reported 'circular membrane ruffling' of fibroblasts 
exposed to platelet-derived growth factor [26]. Thin stress fi- 
bers were also seen along the direction of cell strength (Fig. 
2a.c). F-actin deposition with specific organization at the 
edges of pseudopodia was enhanced by addition of TPA 
(Fig, 2d,e). Sph-l-P-treated cells exhibited stress fibers extend- 
ing in various directions, but showed neither F-actin deposi- 
tion at the cell periphery nor circular staining patterns (Fig. 
2f--h). Quantitative determination of F-actin in F1 cells re- 
vealed a 24% decrease (SE = 9.8%, n = 3) in BODIPY-phal- 
lacidin staining after Sph-l-P treatment. This phenomenon 
was reversible, i.e. subtraction of Sph-l-P from culture med- 
ium led to reappearance of actin rings and pseudopodia nd 
restoration of motility. 
To test whether Sph-I-P inhibits in vitro actin nucleation, 
we used a fluorescence assay with pyrene-labeled actin [24,25]. 
In this assay, fluorescence intensity increases as actin nuclea- 
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Fig. 4. lntracellular changes of Ca 2+ levels in FI cells in the presence ofSph-l-P and related compounds. (a) !ttM Sph-l-P. (b) 5 pM Sph-l- 
P. (¢) 10 ~tM Sph-l-P. (d) 40 IIM dihydro-Sph-l-P. (e) 40 ~tM SPC. (f) 20 pM C2-Cer. The test compound was added at the time indicated by 
solid arrows. ! I~M ionomycin (a calcium ionophore) was added at the time indicated by open arrows. 
tion proceeds. Fig. 3A shows time course of actin nucleation 
mediated by FI cell plasma membranes. No actin nucleation 
was observed without F! cell plasma membranes, but with the 
plasma membranes, actin nucleation was observed as reported 
for plasma membranes from Dictyostelium discoideum 
[2738]. The onset of nucleation was characterized by a lag 
phase which may result from the slow processes of monomer 
activation [29], Sph-l-P at 100 nM inhibited actin nucleation 
mediated by F! cell plasma membranes. Sph-l-P delayed in- 
itiation of the nucleation: in the presence of 100 nM Sph-l-P, 
the nucleation started at 13 rain (compared to 7 min in the 
absence of Sph.l-P) (Fig. 3A), This inhibition of the nuclea- 
tion was dose-dependent (Fig, 3B), At the maximal inhibitory 
concentration of I~  nM, Sph.l.P reduced the nucleation 
43 + 18°/o (n = 3) at 15 rain, Likewise, Sph-l-P had an inhi- 
bitory effect on cell motility at 10 nM-i gM concentrations. 
The inhibitory effect of Sph-l-P was compared with those of 
structurally-related Sph derivatives (Fig. 3C), however, none 
of these compounds inhibited the actin nucleation. 
Intracellular Ca 2+ release from F I cells was induced by 5 
mM Sph-l-P, but was not affected by 0.01-0.1 I~M Sph-l-P, 
the concentration range in which cell motility was strongly 
inhibited, suggesting that the motility-inhibitory effect of 
Sph-l..P may not be due to changes of intracellular Ca 2+ 
mobilization, although further studies are necessa~,. Dihy- 
dro-Sph-l-P and SPC induced Ca 2+ mobilization at 40 ~tM, 
but not at lower concentrations. C2-ceramide induced no 
Ca ~+ mobilization (Fig. 4). 
Cell motility is an important component for development, 
immunity, metastasis and wound healing, but the molecular 
mechanisms and signaling pathways which mediate cell motil- 
ity are largely unknown. The cellular response to chemotactic 
factors is attributed to a dynamic ycle of actin assembly and 
disassembly causing reconstruction of the actin network in 
leading lameilae under control of transmembrane signals 
[30]. Chemotactic factors trigger the formation of actin nu- 
cleation sites through receptors on the cell surface. The rapid 
response of actin nucleation suggests that plasma membranes 
are ;nvolved in the signal transduction, but the intracellular 
site of the actin nucleation is unknown. A fluorescence assay 
with pyrene-labeled actin demonstrated that F I cell plasma 
membranes are necessary for actin nucleation which can be 
inhibited by Sph-l-P. Because Sph-l-P did not interact with 
actin directly (Yamamura, Hakomori and lgarashi, unpub- 
lished), these results indicate that Sph-l-P in the nM range 
interacts with actin nucleation sites or receptors on the plasma 
membranes or other molecules which regulate actin nuclea- 
tion, resulting in inhibition of actin nucleation, polymeriza- 
tion and reorganization of pseudopodium formation, thereby 
controlling cell motility. 
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